Theratechnologies Valor de mercado
Qual é o Valor de mercado de Theratechnologies?
O Valor de mercado de Theratechnologies Inc. é $92.83M
Qual é a definição de Valor de mercado?
A capitalização de mercado é o valor de mercado em um ponto no tempo das ações em circulação de uma empresa de capital aberto, sendo igual ao preço da ação nesse momento multiplicado pelo número de ações em circulação.
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Valor de mercado de empresas na Setor Health Care em NASDAQ em comparação com Theratechnologies
O que Theratechnologies faz?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Empresas com valor de mercado semelhantes a Theratechnologies
- American Resources tem Valor de mercado de $92.75M
- American Resources tem Valor de mercado de $92.75M
- Berkeley Energia tem Valor de mercado de $92.76M
- Arlington Asset Investment tem Valor de mercado de $92.77M
- Inspired PLC tem Valor de mercado de $92.77M
- Capral tem Valor de mercado de $92.78M
- Theratechnologies tem Valor de mercado de $92.83M
- China Yurun Food tem Valor de mercado de $92.88M
- ReposiTrak tem Valor de mercado de $92.92M
- Gabelli Merger Plus+ Trust Plc tem Valor de mercado de $93.01M
- Adams Resources & tem Valor de mercado de $93.02M
- B.L. Kashyap and Sons tem Valor de mercado de $93.09M
- JPMorgan Multi-Asset Trust Plc tem Valor de mercado de $93.13M